0001127602-11-030617.txt : 20111129
0001127602-11-030617.hdr.sgml : 20111129
20111129162656
ACCESSION NUMBER: 0001127602-11-030617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111128
FILED AS OF DATE: 20111129
DATE AS OF CHANGE: 20111129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pietrusko Robert
CENTRAL INDEX KEY: 0001398219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21699
FILM NUMBER: 111231557
MAIL ADDRESS:
STREET 1: 397 EAGLEVIEW BOULEVARD
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VIROPHARMA INC
CENTRAL INDEX KEY: 0000946840
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232789550
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 STOCKTON DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 6104587300
MAIL ADDRESS:
STREET 1: 730 STOCKTON DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
4
1
form4.xml
PRIMARY DOCUMENT
X0304
4
2011-11-28
0000946840
VIROPHARMA INC
VPHM
0001398219
Pietrusko Robert
730 STOCKTON DRIVE
EXTON
PA
19341
1
VP, Regulatory & Quality
Common Stock
2011-11-28
4
M
0
19000
9.99
A
22910
D
Common Stock
2011-11-28
4
S
0
19000
23.00
D
3910
D
Employee Stock Option (Right to Buy)
9.99
2011-11-28
4
M
0
19000
0
D
2009-06-13
2018-06-13
Common Stock
19000
35000
D
The options vest in four equal annual installments beginning on the first anniversary date from time of grant.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2011.
/s/ J. Peter Wolf, attorney-in-fact
2011-11-29